References
- American Lung Association. Asthma in children fact sheet, Available from http://www.lungusa.org/asthma/ascpedfac99.html (Accessed March 2002)
- American Academy of Allergy, Asthma & Immunology. Pediatric Asthma, Promoting Best Practice. Guide for Managing Asthma in Children. AAAAI, Milwaukee 1999
- Billings J, Kretz S E, Rose R, Rosenbaum S, Sullivan M, Fowles J, Weiss K B. National Asthma Education and Prevention Program Working Group Report on the Financing of Asthma Care. Am J Respir Crit Care Med 1996; 154(3 pt 2)S119–S130
- Perrin J M, Homer C J, Berwick D M, Woolf A D, Freeman J L, Wennberg J E. Variations in rates of hospitalization of children in three urban communities. N Engl J Med 1989; 320(18)1183–1187
- Weiss K B, Gergen P J, Hodgson T A. An economic evaluation of asthma in the United States. N Engl J Med 1992; 326(13)862–866
- Smith D H, Malone D C, Lawson K A, Okamoto L J, Battista C, Saunders W B. A national estimate of the economic costs of asthma. Am J Respir Crit Care Med 1997; 156(3 pt 1)787–793
- National Asthma Education and Prevention Program. Expert Panel Report 2: Guidelines for the Diagnosis and Management of Asthma. NIH publication no. 97‐4051, National Heart, Lung and Blood Institute, Bethesda, MD 1997
- National Asthma Education and Prevention Program. Expert Panel Report 2: Guidelines for the Diagnosis and Management of Asthma—Update on Selected Topics 2002. NIH publication no. 02‐5075, National Heart, Lung and Blood Institute, Bethesda, MD 2002
- Baker J W, Mellon M, Wald J, Welch M, Cruz‐Rivera M, Walton‐Bowen K. A multiple‐dosing, placebo‐controlled study of budesonide inhalation suspension given once or twice daily for treatment of persistent asthma in young children and infants. Pediatrics 1999; 103(2)414–421
- Kemp J P, Skoner D, Szefler S J, Walton‐Bowen K, Cruz‐Rivera M, Smith J A. Once‐daily budesonide inhalation suspension for asthma in infants and children 6 months to 8 years of age. Ann Allergy Asthma Immunol 1999; 83(3)231–239
- Shapiro G, Mendelson L, Kraemer M J, Cruz‐Rivera M, Walton‐Bowen K, Smith J A. Efficacy and safety of budesonide inhalation suspension (Pulmicort Respules) in young children with inhaled steroid‐dependent, persistent asthma. J Allergy Clin Immunol 1998; 102(5)789–796
- De Blic J, Delacourt C, Le Bourgeois M, Mahut B, Ostinelli J, Caswell C, Scheinmann P. Efficacy of nebulized budesonide in treatment of severe infantile asthma: a double‐blind study. J Allergy Clin Immunol 1996; 98(1)14–20
- Ilangovan P, Pedersen S, Godfrey S, Nikander K, Noviski N, Warner J O. Treatment of severe steroid dependent preschool asthma with nebulized budesonide suspension. Arch Dis Child 1993; 68(3)356–359
- De Jongste J C, Duiverman E J. Nebulised budesonide in severe childhood asthma. Lancet 1989; 1(8651)1388
- Childhood Asthma Management Program Research Group. Long‐term effects of budesonide or nedocromil in children with asthma. N Engl J Med 2000; 343(15)1054–1063
- Scott M B, Skoner D P. Short‐term and long‐term safety of budesonide inhalation suspension in infants and young children with persistent asthma. J Allergy Clin Immunol 1999; 104(4 pt 2)S200–S209
- Greineder D K, Loane K C, Parks P. A randomized controlled trial of a pediatric asthma outreach program. J Allergy Clin Immunol 1999; 103(3 pt 1)436–440
- Kelly C S, Morrow A L, Shultz J, Nakas N, Strope G L, Adelman R D. Outcomes evaluation of a comprehensive intervention program for asthmatic children enrolled in Medicaid. Pediatrics 2000; 105(5)1029–1035